První informace o pracovním setkání SAU, listopad 2011 a nástin další činnosti

doc. MUDr. Miroslav Hanuš, CSc.

Urol. praxi, 2011; 12(5): 275  

Doba jedová

prof. RNDr. Anna Strunecká, DrSc.

Urol. praxi, 2011; 12(5): 277  

Treatment of painful syndromes in urology

MUDr.Pavlína Nosková

Urol. praxi, 2011; 12(5): 282-286  

The artical discuss pathophysiology in general, particularly treatment possibilies of acute and chronic pain in Chronic pain requires multidisciplinary access with optimal use of pharmacotherapy, psychotherapy, invasive methods and physiotherapy resulting from cooperation of urologist and algesiologist.

Strategy of treatment for recurrent cystitis in women

MUDr.Michael Pešl, FEBU

Urol. praxi, 2011; 12(5): 288-291  

Roughly half of women suffer at least one episode of acute cystitis during their life. In as many as one-third of them, the condition recurs. This may be caused by a persistent infection due to an inflammatory focus or reinfection with another bacterial strain after a longer time interval. In the case of reinfections, pharmacotherapy is usually sufficient, with long-term antibiotic prophylaxis being the standard method of choice. Promising results have been obtained with the use of Uro-Vaxom. Also of importance are regimen measures. When urinary infection is persistent, it is necessary to find and remove its cause.

Prostate cancer radiotherapy - related complications, their prevention and treatment

MUDr.Irena Čoupková, MUDr.Petr Čoupek, MUDr.Pavel Krupa, prof.MUDr.Pavel Šlampa, CSc.

Urol. praxi, 2011; 12(5): 292-294  

Radiotherapy for prostate cancer is connected with urinary and gastrointestinal toxicity. We distinguish two types of adverse effects: early (acute) and late (chronic). In the course of radiotherapy and shortly after the treatment completion we can expect intestinal frequency, tenesmus, diarrhoea, rectal bleeding, pollakisuria, dysuria, acute urinary retention and hematuria. Late sequelae of radiotherapy originate several months till years after the treatment and manifest as postradiation proctitis and cystitis, rectal a urethral strictures, ulcers, bowel obstruction and perforation and fistulae. 40–50 % patiens with prostate cancer treated...

Management of postactinic urinary complications after radiotherapy for prostate cancer

MUDr.Daniel Macík, MUDr.Michal Staník, doc.MUDr.Jan Doležel, Ph.D.

Urol. praxi, 2011; 12(5): 295-297  

Aim of this article is to present a brief overview of the management of complications after prostate cancer radiotherapy using conservative and surgical measures

Gastrointestinal toxicity after radiation therapy for prostate cancer

MUDr.Milana Šachlová, CSc., Ph.D., MUDr.Martin Ondrák, Ph.D., MUDr.Ivo Novotný, CSc., Vlastimil Polko, DiS.

Urol. praxi, 2011; 12(5): 298-300  

The gastrointestinal toxicity is an important dose-limiting factor of prostate cancer treatment. The gastrointestinal toxicity can affect the quality of life in patiens after radiotherapy. We review the concept of treating such patiens.

Anuria

prof.MUDr.Miroslav Merta, CSc.

Urol. praxi, 2011; 12(5): 302-305  

Anuria is a significant decrease in daily output or its complete absence. Anuria is usually a sign of renal failure; acute anuria is a sign of acute renal failure and may be reversible while long-term or persistent anuria is a sign of chronic renal failure and is irreversible. It is a serious condition associated with significant morbidity/mortality. The prognosis of anuria in acute renal failure is closely dependent on the causative agent, the degree of kidney damage at diagnosis and the quality of treatment provided.

Postpartum incontinence, pregnancy and labour and their relation to female urinary incontinence

MUDr.Atanas Ivan Belkov, doc.MUDr.Martin Huser, Ph.D., MUDr.Marcela Pastorčáková, MUDr.Kateřina Sedláková

Urol. praxi, 2011; 12(5): 307-311  

The aim of the paper is to provide an overview of the physiological changes in the female body during pregnancy and their impact on urine collection and evacuation. The end result of these changes is physiological pollakisuria. Also described are the risk factors that may, during pregnancy and labour, lead to the development of urinary incontinence. The importance of prevention and of possible therapeutic options is emphasised.

Hormonal therapy and low risk prostate cancer?

MUDr.David Hradil, MUDr.Milan Král, Ph.D., MUDr.Igor Hartmann, doc.MUDr.Vladimír Študent, Ph.D.

Urol. praxi, 2011; 12(5): 313-314  

The author presents a case of patient with low risk prostate cancer, who underwent atypicly combination therapy (hormonal therapy and planned currative radiotherapy). We mention possibilities of treatment according to the last version of EAU Guidelines 2010.

Urethral catheter as a risk factor of urologic complications after total hip arthoplasty - the retrospective analysis

MUDr.Jana Amrichová, MUDr.Maroš Hrubina, MUDr.Jaromír Pangrác

Urol. praxi, 2011; 12(5): 315-318  

We have evaluated our group of patients after total hip arthroplasty focusing on the urologic complications of which there is 16 %. The incidence in men is 21.8 %. The total of 11 out of 124 men have undergone one or more urologic operations after the replacement. The incidence in women is 11.5 %. Meanwhile 2 out of 157 women have undergone other urologic procedures. All patients had indwelling catheter after the orthopaedic operation. The average indwelling period is 5 days in general, in patients with complications it is 6 days. Longer indwelling period increases the risk of urologic complication´s incidence. The risk factor is man over 65...

Urinary tract infections in children

Mária Čubáková, Mgr.Nataša Sochorová, MUDr.Aleš Vidlář

Urol. praxi, 2011; 12(5): 319-320  

Urinary tract infections in children are among the most frequent diseases, second only to respiratory infections. In infancy, these infections are more common in boys while at school age girls are more commonly affected. Any urinary tract disease can mean possible complications; therefore, early diagnosis and prompt treatment are essential. Urinary tract infections may be an independent disease; however, they often accompany other conditions. They may have a mild course and subside without sequelae but also may result in damage to renal tissue (parenchyma) and severe functional impairment and renal failure.

Pioglitazon a mírné zvýšení rizika karcinomu močového měchýře Informace SÚKL

MUDr.Eva Jirsová

Urol. praxi, 2011; 12(5): 321-322  

Zdravotnické prostředky předepisované na poukaz

Urol. praxi, 2011; 12(5): 323-324  

Autodidaktický test 5/2011

Urol. praxi, 2011; 12(5): 325-326